Fresenius SE KGaA (XSWX:FRE) Net Margin %: 7.48% (As of Mar. 2026) — 41% Above Median


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF35.86
GF Value CHF32.85
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Net Margin %?

Fresenius SE KGaA XSWX:FRE 71 Net Margin % is 7.48% as of Mar. 2026, which is 41% above its 10-year median of 5.31. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.85 (Fairly Valued). The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 66.17% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Fresenius SE KGaA's Net Income for the three months ended in Mar. 2026 was CHF396 Mil. Fresenius SE KGaA's Revenue for the three months ended in Mar. 2026 was CHF5,295 Mil. Therefore, Fresenius SE KGaA's net margin for the quarter that ended in Mar. 2026 was 7.48%.

The historical rank and industry rank for Fresenius SE KGaA's Net Margin % or its related term are showing as below:

XSWX:FRE' s Net Margin % Range Over the Past 10 Years
Min: -2.82   Med: 5.31   Max: 6.38
Current: 6.38


XSWX:FRE's Net Margin % is ranked better than
66.17% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 2.885 vs XSWX:FRE: 6.38

Fresenius SE KGaA  (XSWX:FRE) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Fresenius SE KGaA Net Margin % Related Terms


Fresenius SE KGaA Net Margin % Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Net Margin % Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.85 6.37 -2.82 2.15 5.53

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.01 5.91 6.27 5.86 7.48

XSWX:FRE vs HCA, THC, DVA: Net Margin % Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA Net Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Net Margin % distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Net Margin % falls into.


XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Fresenius SE KGaA's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=1179.487/21343.669
=5.53 %

Fresenius SE KGaA's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=395.925/5295.389
=7.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 7.48% mean?
Fresenius SE KGaA (XSWX:FRE) has a Net Margin % of 7.48% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Fresenius SE KGaA and its competitors. This is 41% above median its historical median of 5.31. According to the industry distribution chart, Fresenius SE KGaA ranks #226 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 33.8%.
Is Fresenius SE KGaA's Net Margin % too high?
Fresenius SE KGaA's current Net Margin % of 7.48% is 41% above median its 10-year median of 5.31. The Healthcare Providers & Services industry median Net Margin % is 2.89. Fresenius SE KGaA's value of 7.48% is 159.3% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #226 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #226 out of 668 companies for Net Margin %. This puts Fresenius SE KGaA in the upper half of its industry. The industry median Net Margin % is 2.89. Fresenius SE KGaA's value of 7.48% is 159.3% above this benchmark. While the company's 10-year median is 5.31 vs. the industry median of 2.89, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Net Margin % of 7.48% is 159.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Net Margin % is 7.48%, which is 41% above median its own 10-year median of 5.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF32.85, compared to a current price of CHF35.86 — trading 9.2% above its estimated fair value. The current Net Margin % is 7.48%, which is 41% above median its 10-year median of 5.31 and 159.3% above the Healthcare Providers & Services industry median of 2.89. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Net Margin % is 7.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF35.86 is trading 9.2% above its estimated GF Value™ of CHF32.85. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XSWX:FRE:

  • Net Margin %: 7.48% (41% above median its 10-year median of 5.31)
  • GF Value™: CHF32.85 vs. price of CHF35.86 (9.2% above fair value)
  • GF Score™: 71/100 with 5 warning signs
  • Industry Position: 159.3% above the Healthcare Providers & Services median (#226 of 668)

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF35.86
Price
CHF32.85
GF Value